Cargando…
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
To successfully protect against pathogen infection, a vaccine must elicit efficient adaptive immunity, including B and T cell responses. While B cell responses are key, as they can mediate antibody-dependent protection, T cells can modulate B cell activity and directly contribute to the elimination...
Autores principales: | Bettini, Emily, Locci, Michela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918810/ https://www.ncbi.nlm.nih.gov/pubmed/33673048 http://dx.doi.org/10.3390/vaccines9020147 |
Ejemplares similares
-
Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients
por: Crane, Clarkson, et al.
Publicado: (2021) -
Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders
por: Iwayama, Hideyuki, et al.
Publicado: (2022) -
Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients
por: Kermond, Rachael F., et al.
Publicado: (2022) -
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
por: Lederer, Katlyn, et al.
Publicado: (2022) -
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)